AlphaCentric Advisors »

Madrigal Pharmaceuticals shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $93k 178 523.47

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Astrazeneca Ord (AZN)
Vertex Pharmaceuticals Incorporated (VRTX)
Euronet Worldwide (EEFT)
Invitation Homes (INVH)
Ionis Pharmaceuticals (IONS)
Insmed Com Par $.01 (INSM)
Incyte Corporation (INCY)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
AMREP Corporation (AXR)
Saul Centers (BFS)

View all positions for AlphaCentric Advisors

Top funds holding Madrigal Pharmaceuticals

Baker Bros. Advisors
Henderson Group
Rtw Investments
Vanguard Group
venBio Select Advisor
BlackRock
Paulson & Co
Vanguard Portfolio Management
Vanguard Capital Management
Citadel Advisors
State Street Corporation
Wellington Management Company
Geode Capital Management
FMR
William Blair Investment Management

View all funds holding Madrigal Pharmaceuticals